SCHEMBL3897583

SCHEMBL3897583

O=C(O)N(OCc1ccccc1)c1cc(O)cc(O)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
LMNA P02545 2/20 0.40
KMT2A Q03164 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
PDK1 Q15118 1/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 1/20 0.38
SLC5A1 P13866 1/20 0.38
SLC5A2 P31639 1/20 0.38
MAOB P27338 1/20 0.38
TSHR P16473 1/20 0.38
TSPO P30536 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779724 0.86 ALDH1A1 (0.46) ALDH1A1LMNAKMT2ATDP1MAPK1
SCHEMBL3903283 0.75 LTA4H (0.42) ALDH1A1LMNAKMT2AMAPK1L3MBTL1
SCHEMBL9435731 0.73 MAPT (0.51) ALDH1A1LMNAKMT2APDK1MEN1
SCHEMBL14588682 0.72 ALDH1A1 (0.52) ALDH1A1LMNAKMT2ATDP1MAPK1
SCHEMBL7667460 0.72 ALDH1A1 (0.47) ALDH1A1LMNAKMT2ATDP1MAPK1
SCHEMBL8316594 0.72 ALDH1A1 (0.50) ALDH1A1LMNAKMT2ATDP1MAPK1
SCHEMBL8779621 0.72 TRPM8 (0.51) ALDH1A1LMNAKMT2ATDP1MAPK1
SCHEMBL13479774 0.71 KMT2A (0.49) ALDH1A1LMNAKMT2ATDP1L3MBTL1
SCHEMBL10627501 0.69 ALDH1A1 (0.52) ALDH1A1KMT2ATDP1MAPK1L3MBTL1
Hydrochloric Acid SCHEMBL38652255 0.69 ALDH1A1 (0.47) ALDH1A1LMNAKMT2ATDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572459-B2 Prevention infections in humans, animals STARPHARMA PTY LTD. (AU) 2009-08-11 US disclosed
US-20030129158-A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions STARPHARMA LIMITED 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030129158-A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions FUT6, B3GNT2, SIGLEC7 ALDH1A1 2800/4885LMNA 1561/4885KMT2A 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.